BIRC2 and pancreatic neoplasm: The expression of cIAP1 inhibited AZD5582-induced cell death and TNFα production (Figure 4E and Supplementary Figure S7B), indicating that AZD5582 targets cIAP1 in human pancreatic cancer cells.